Breakthrough drug gives women with aggressive form of breast cancer six months longer to live without condition worsening

Breakthrough drug gives women with aggressive form of breast cancer six months longer to live without condition worsening | UPDATED: 11:48 GMT, 9 December 2012 A new breakthrough drug cuts the risk of dying early by one-third for women with an aggressive form of breast cancer.

Is this the world’s cutest cat? Heart-meltingly adorable animal caught on camera playing on a chair

Is this the world”s cutest cat Heart-meltingly adorable animal caught on camera playing on a chair. Meet Ksenia, a Scottish Fold feline from Russia and what thousands of internet users are calling the world”s cutest cat.

Suddenly that holiday kiss from grandma becomes a lot more terrifying: Deadly MRSA bacteria may be lurking on dirty dentures, claim scientists

Deadly MRSA bacteria could be lurking on grandma's DENTURES, say scientists | UPDATED: 13:37 GMT, 7 April 2012 Scientists have warned false teeth could be infected with killer bugs like MRSA – and have advised wearers to microwave them.

Strict diet for two days "better than calorie counting all week"

Strict diet for two days “better than calorie counting all week” Women who stuck to fruit, vegetables and lean meat lost nearly twice as much weight than those constantly dieting Following a strict diet for just two days of the week is a far more effective way to lose weight than trying to calorie count all the time, researchers claim. They found that women who stuck to fruit, vegetables and lean meat for two days a week while being allowed to eat as much as they liked on the other days lost nearly twice as much weight than those who were dieting constantly.

Drug that can keep breast cancer at bay for longer

Breakthrough drug that can keep breast cancer at bay for longer Breakthrough: Women on pertuzumab alongside “wonder” drug Herceptin lived for 18 months without symptoms worsening A breakthrough drug gives women suffering an aggressive form of breast cancer an extra six months before the disease advances. Women on a combination treatment of pertuzumab alongside the ‘wonder’ drug Herceptin lived on average for 18 months without their disease worsening, compared with 12 months for those not taking it